Atelerix and Rodon Global partner to integrate cryo-free preservation technology into specialist logistics solutions
Initial agreement to incorporate Atelerix’s non-cryogenic cell preservation technology into international freight and logistics services for drug discovery and clinical trials
Qureight appoints Craig Rhodes as Head of Partnerships to lead on pharma relationship management
Appointment underscores Qureight’s commitment to drive adoption of its AI-powered imaging and clinical data curation platform to support clinical trials and accelerate drug development timelines for lung and heart diseases.
Paragraf closes $55M Series C funding round
Paragraf pioneers graphene-based electronics with standard semiconductor processes, producing magnetic sensors and GMS while developing advanced devices.
Monument Therapeutics to trial schizophrenia therapy in partnership with FNIH
The trial is a component of the Accelerating Medicines Partnership Schizophrenia programme, managed by FNIH.
Forefront RF makes leadership changes for next stage of global growth
Dynamic tech duo Rupert Baines and former chair Phil O'Donovan have been unveiled as a new executive leadership team to spearhead a fresh push for global growth by Cambridge fabless semiconductor company Forefront RF.
Sunil Shah and Dr Catherine Elton join Atelerix’s Board to drive global commercial expansion
Industry-leaders Sunil Shah (CEO, o2h Ventures) and Dr Catherine Elton (CBO, Axol Bioscience) appointed as Chair and Non-Executive Director, respectively
Thought Machine supports Zopa Bank to launch Biscuit
Thought Machine, a cloud-native banking technology company, has partnered with Zopa Bank to launch its current bank account Biscuit.
Tasty new deal as Xampla goes Bunzi jumping
Cambridge-based materials innovation company, Xampla, has heralded a major commercial advance as Bunzl UK & Ireland adds Huhtamaki’s ‘Taste’ hot food boxes with Morro Coating to its comprehensive range of food service packaging.
Cotton Mouton Diagnostics Disrupts Endotoxin Testing
Cotton Mouton Diagnostics, a cutting-edge UK-based diagnostics technology company, has received a half-a-million-pound investment from CPI Enterprises, the investment arm of CPI, as part of the Innovate UK Catapult Associated Fund.
Qureight analyses of Insilico Medicine’s Phase IIa rentosertib data support preliminary efficacy results and future trial expansion
Qureight, a techbio company accelerating drug development using its proprietary deep-learning image biomarkers and clinical data analytics platform, today announced the first results from a collaboration with Insilico Medicine (“Insilico”), a clinical-stage biotechnology company driven by generative AI, focused on rentosertib (ISM001-055), a novel TNIK inhibitor discovered using Insilico's generative AI approach, in development for the treatment of IPF.
ZeroRISC Appoints Zakir Durumeric and David Gammon to Board of Directors
ZeroRISC, a leader in open-source silicon supply chain integrity, has appointed Zakir Durumeric, Stanford Professor and Censys Founder, and David Gammon, CEO and founder of Rockspring, to its Board of Directors.
$40m 'Superman' backed fund partners with Healx to fight paralysis
A $40 million London-based fund backed by the Christopher & Dana Reeve Foundation, among others, today unveils its first major investment – and Cambridge AI drug discovery company Healx is the beneficiary.
Oxford Space Systems deploys S-Band helical antenna for Astro Digital enhancing satellite communication capabilities
Oxford Space Systems, a leading innovator in deployable antennas for space, was successful with the on-orbit deployment of an S-band isoflux helical antenna for Astro Digital, a provider of satellite systems.
Monument Therapeutics Reports Positive Phase I Results for Novel Cognitive Impairment Associated with Schizophrenia Treatment
Monument Therapeutics, a precision neuroscience company, today announced positive topline results from its Phase I clinical trial evaluating MT1988, a novel treatment targeting cognitive impairment associated with schizophrenia (CIAS).
Singular Photonics and AMS Technologies to bring advanced SPAD sensors to Europe
Singular Photonics, a developer of image sensor technologies, has announced a strategic partnership with AMS Technologies, a distributor and solution provider for optical technologies.
AI foot scanner could help prevent hospital stays
An at-home 'foot-recognition' scanner could prevent heart failure hospitalisations, a study has found.
DHL eCommerce UK and HubBox collaboration enables retailers to integrate Pickup at Checkout software
DHL eCommerce UK has partnered with HubBox in a bid to make it easy for retailers to offer out-of-home deliveries and enhance the shopper experience with international orders.
Psyomics wins NHS Innovation Accelerator to drive NHS adoption
Digital mental health company Psyomics has announce that its CEO, Dr Melinda Rees, has been awarded a prestigious NHS Innovation Accelerator (NIA) Fellowship.
Woolland steps up to steer fresh growth phase for Closed Loop Medicine
Closed Loop Medicine, a leader in pharmaceutical precision dosing, has promoted Kate Woolland to Chief Executive Officer. She was previously Chief Operating Officer for the company, which has facilities at Babraham Research Campus.
Archer enters partnership with Paragraf for Biochip development
Archer Materials, a company developing quantum technology for medical diagnostics, has signed an agreement with UK graphene-based electronics company Paragraf.